title: Experiences of gamma hydroxybutyrate (GHB) ingestion: a focus group study.
abstract: GHB (gamma hydroxybutyrate) is a significant new drug of abuse added to the United States Controlled Substance Act in 2000. The majority of the published literature on GHB consists of clinical case reports, mainly from emergency departments, and a collection of laboratory-based studies, focused mainly on anesthesia. While comments about the various experiences and behaviors of human users are often included in such studies or reports, these aspects of GHB are only just beginning to be systematically investigated or detailed. Reported here are data from a qualitative study using focus group methods on the consumption habits, experiences, and beliefs of GHB users. A total of 51 people, 30 men and 21 women, mean age of 31.1+/-7.6 years (range 18 to 52 years), who report having used GHB for an average of 4.3+/-2.5 years (range one to 11 years), were interviewed in 10 separate groups held in 2004. This article discusses broadly the general experience of the GHB high, major perceived benefits including sexual responses to the drug, perceived risks and dangers of ingestion, co-ingestion, and various contexts of use. It concludes with a discussion of the implications drawn from this information for clinicians treating patients who use GHB.
authors: Department of Anthropology, History & Social Medicine, University of California, San Francisco 94143-0850, USA. barkerj@dahsm.ucsf.edu
authors: Judith C
authors: JC
authors: Barker
authors: Shana L
authors: SL
authors: Harris
authors: Jo E
authors: JE
authors: Dyer
mesh_terms: D000293:Adolescent; D000328:Adult; D005260:Female; D017144:Focus Groups; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D013287:Illicit Drugs / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D018570:Risk Assessment; D012725:Sexual Behavior / Q000187:drug effects; D012978:Sodium Oxybate / Q000008:administration & dosage / Q000009:adverse effects*; D019966:Substance-Related Disorders / Q000453:epidemiology* / Q000523:psychology*
chemical_list: D013287:Illicit Drugs; D012978:Sodium Oxybate
references: Am J Psychiatry. 2005 Aug;162(8):1494-502
references: 16055770
references: J Clin Psychopharmacol. 2006 Oct;26(5):524-9
references: 16974199
references: Am J Addict. 2001 Summer;10(3):232-41
references: 11579621
references: Am J Public Health. 2001 Jun;91(6):953-8
references: 11392940
references: Schweiz Med Wochenschr. 2000 Mar 11;130(10):356-61
references: 10763213
references: Int J Drug Policy. 2006 Jan 1;17(1):23-28
references: 23543728
references: Clin Pharmacol Ther. 2007 Feb;81(2):178-84
references: 17192771
references: Addict Behav. 2006 Jan;31(1):137-42
references: 15907371
references: Am Fam Physician. 2004 Jun 1;69(11):2619-26
references: 15202696
references: Ann Emerg Med. 2003 Jul;42(1):3-8
references: 12827115
references: Ann Emerg Med. 2006 Feb;47(2):177-83
references: 16431231
references: J Subst Abuse. 2001;13(1-2):119-26
references: 11547613
references: J Psychoactive Drugs. 2004 Sep;36(3):401-2
references: 15559687
references: N Engl J Med. 2005 Jun 30;352(26):2721-32
references: 15987921
references: Ann Emerg Med. 1998 Jun;31(6):716-22
references: 9624311
references: Drug Alcohol Depend. 2002 Jun 1;67(1):89-94
references: 12062782
references: Am J Addict. 2004 Mar-Apr;13(2):120-7
references: 15204663
references: Am J Emerg Med. 2005 May;23(3):316-20
references: 15915404
references: J Med Toxicol. 2007 Mar;3(1):7-14
references: 18072152
references: Subst Use Misuse. 2008;43(11):1507-20
references: 18752156
references: Subst Use Misuse. 2005;40(9-10):1203-40
references: 16048814
references: Drug Alcohol Depend. 2001 Sep 1;64(1):9-17
references: 11470336
references: Addiction. 2003 Feb;98(2):199-204
references: 12534425
references: Addiction. 2003 Dec;98(12):1693-703
references: 14651501
references: CMAJ. 2000 Jun 27;162(13):1843-8
references: 10906922
references: N Engl J Med. 2001 Jan 11;344(2):87-94
references: 11150358